Accessibility Menu
 

Opus Genetics

(NASDAQ) IRD

Current Price$4.39
Market Cap$312.34M
Since IPO (2020)-27%
5 Year-39%
1 Year+282%
1 Month+17%

Opus Genetics Financials at a Glance

Market Cap

$312.34M

Revenue (TTM)

$14.20M

Net Income (TTM)

$49.59M

EPS (TTM)

$-0.84

P/E Ratio

-5.21

Dividend

$0.00

Beta (Volatility)

0.92 (Low)

Price

$4.39

Volume

847,023

Open

$4.56

Previous Close

$4.39

Daily Range

$4.34 - $4.67

52-Week Range

$0.65 - $5.30

IRD News

No articles available.

IRD: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Opus Genetics

Industry

Biotechnology

Employees

28

CEO

George Magrath, III, MD

Headquarters

Durham, MI 48335, US

IRD Financials

Key Financial Metrics (TTM)

Gross Margin

57%

Operating Margin

-3%

Net Income Margin

-3%

Return on Equity

-449%

Return on Capital

-91%

Return on Assets

-99%

Earnings Yield

-19.19%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$312.34M

Shares Outstanding

71.15M

Volume

847.02K

Short Interest

0.00%

Avg. Volume

918.15K

Financials (TTM)

Gross Profit

$14.14M

Operating Income

$38.60M

EBITDA

$38.60M

Operating Cash Flow

$35.25M

Capital Expenditure

$0.00

Free Cash Flow

$35.25M

Cash & ST Invst.

$45.09M

Total Debt

$0.00

Opus Genetics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$3.87M

-10.2%

Gross Profit

$3.85M

+210.8%

Gross Margin

99.66%

N/A

Market Cap

$312.34M

N/A

Market Cap/Employee

$17.35M

N/A

Employees

18

N/A

Net Income

$16.52M

+53.0%

EBITDA

$11.44M

-14.1%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$45.09M

+48.7%

Accounts Receivable

$3.17M

-45.2%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-98.70%

N/A

Return on Invested Capital

-90.90%

N/A

Free Cash Flow

$9.83M

-32.2%

Operating Cash Flow

$9.83M

-32.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ALECAlector, Inc.
$2.05-0.49%
ABOSAcumen Pharmaceuticals, Inc.
$2.67-8.56%
AGENAgenus Inc.
$3.71-2.62%
HURATuHURA Biosciences, Inc.
$1.94+8.38%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
RITMRithm Capital
$8.77-0.03%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.82+0.06%
INFYInfosys
$13.12+0.01%

Questions About IRD

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.